Notice2023-10212
Asim A. Hameedi, M.D.; Stay of Decision and Transmittal Order
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 12, 2023
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 92 (Friday, May 12, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 92 (Friday, May 12, 2023)]
[Notices]
[Page 30784]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-10212]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Asim A. Hameedi, M.D.; Stay of Decision and Transmittal Order
On April 4, 2023, the Agency issued a Decision and Order revoking,
effective May 11, 2023, Certificate of Registration No. BH6407919
issued to Asim A. Hameedi, M.D.\1\ Asim A. Hameedi, M.D., 88 FR 21,715
(April 11, 2023). By letter dated May 1, 2023 (letter), addressed to
the Drug Enforcement Administration Administrator, Dr. Hameedi
requested that the April 4, 2023 Order be vacated \2\ because, among
other reasons, he was never served with the underlying Order to Show
Cause. Letter, at 1. Given the content of the letter and its
attachments, I hereby stay the revocation of Certificate of
Registration No. BH6407919 issued to Asim A. Hameedi, M.D., pending
further proceedings. Asim A. Hameedi, M.D., 88 FR 21,715 (April 11,
2023).
---------------------------------------------------------------------------
\1\ The Order also denied any pending application to renew or
modify this registration and denied any other pending application by
Dr. Hameedi for registration in New York.
\2\ Dr. Hameedi also seeks to ``excuse his default'' citing to
21 CFR 1301.43(c)(1) and (f)(3). Letter, at 1. The default
procedures Dr. Hameedi references did not become effective until
December 14, 2022, and do not apply to his Order to Show Cause. 87
FR 73,246 (Nov. 29, 2022).
---------------------------------------------------------------------------
This matter is transmitted to the Office of Administrative Law
Judges to conduct any and all appropriate proceedings (for example, to
determine the sufficiency of notice and/or whether good cause exists to
justify any delay).
It is so ordered.
Signing Authority
This document of the Drug Enforcement Administration was signed on
May 9, 2023, by Administrator Anne Milgram. That document with the
original signature and date is maintained by DEA. For administrative
purposes only, and in compliance with requirements of the Office of the
Federal Register, the undersigned DEA Federal Register Liaison Officer
has been authorized to sign and submit the document in electronic
format for publication, as an official document of DEA. This
administrative process in no way alters the legal effect of this
document upon publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2023-10212 Filed 5-11-23; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on May 12, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.